Richard J Czosek1, Jeffrey B Anderson2, Shankar Baskar2, Philip R Khoury3, Natalie Jayaram4, David S Spar2. 1. Division of Cardiology, Department of Pediatrics, Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio. Electronic address: richard.czosek@cchmc.org. 2. Division of Cardiology, Department of Pediatrics, Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio. 3. Division of Cardiology, Department of Pediatrics, Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 4. Division of Cardiology, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri.
Abstract
BACKGROUND: Mortality in cohorts with a single ventricle remains high with multiple associated factors. The effect of heart block during stage I palliation remains unclear. OBJECTIVE: The purpose of this study was to study patient and surgical risks of heart block and its effect on 12-month transplant-free survival in patients with a single ventricle. METHODS: Patient, surgical, outcome data and heart block status (transient and permanent) were obtained from the National Pediatric Cardiology Quality Improvement Collaborative single ventricle database. Bivariate analysis was performed comparing patients with and without heart block, and multivariate modeling was used to identify variables associated with block. One-year outcomes were analyzed to identify variables associated with lower 12-month transplant-free survival. RESULTS: In total, 1423 patients were identified, of whom 28 (2%) developed heart block (second degree or complete) during their surgical admission. Associated risk factors for block included heterotaxy syndrome (odds ratio [OR] 6.4) and atrial flutter/fibrillation (OR 3.8). Patients with heart block had lower 12-month survival, though only in patients with complete heart block as opposed to second degree block. At 12 months of age, 43% (12/28) of patients with heart block died and were more likely to experience mortality at 12 months than patients without block (OR 4.9; 95% confidence interval 1.4-17.5; P = .01). CONCLUSION: Although rare, complete heart block after stage I palliation represents an additional risk of poor outcomes in this high-risk patient population. Heterotaxy syndrome was the most significant risk factor for the development of heart block after stage I palliation. The role of transient block in outcomes and potential rescue with long-term pacing remains unknown and requires additional study.
BACKGROUND: Mortality in cohorts with a single ventricle remains high with multiple associated factors. The effect of heart block during stage I palliation remains unclear. OBJECTIVE: The purpose of this study was to study patient and surgical risks of heart block and its effect on 12-month transplant-free survival in patients with a single ventricle. METHODS: Patient, surgical, outcome data and heart block status (transient and permanent) were obtained from the National Pediatric Cardiology Quality Improvement Collaborative single ventricle database. Bivariate analysis was performed comparing patients with and without heart block, and multivariate modeling was used to identify variables associated with block. One-year outcomes were analyzed to identify variables associated with lower 12-month transplant-free survival. RESULTS: In total, 1423 patients were identified, of whom 28 (2%) developed heart block (second degree or complete) during their surgical admission. Associated risk factors for block included heterotaxy syndrome (odds ratio [OR] 6.4) and atrial flutter/fibrillation (OR 3.8). Patients with heart block had lower 12-month survival, though only in patients with complete heart block as opposed to second degree block. At 12 months of age, 43% (12/28) of patients with heart block died and were more likely to experience mortality at 12 months than patients without block (OR 4.9; 95% confidence interval 1.4-17.5; P = .01). CONCLUSION: Although rare, complete heart block after stage I palliation represents an additional risk of poor outcomes in this high-risk patient population. Heterotaxy syndrome was the most significant risk factor for the development of heart block after stage I palliation. The role of transient block in outcomes and potential rescue with long-term pacing remains unknown and requires additional study.
Authors: Bhavya Trivedi; P Brian Smith; Piers C A Barker; James Jaggers; Andrew J Lodge; Ronald J Kanter Journal: Am Heart J Date: 2011-01 Impact factor: 4.749
Authors: Matthew E Oster; Shan Chen; Nicholas Dagincourt; Yaniv Bar-Cohen; Matthew Brothers; Nicole Cain; Steven D Colan; Richard J Czosek; Jamie A Decker; David G Gamboa; Salim F Idriss; Joel A Kirsh; Martin J LaPage; Richard G Ohye; Elizabeth Radojewski; Maully Shah; Eric S Silver; Anoop K Singh; Joel D Temple; John Triedman; Jonathan R Kaltman Journal: J Thorac Cardiovasc Surg Date: 2016-11-16 Impact factor: 5.209
Authors: Peter C Frommelt; Lin T Guey; L LuAnn Minich; Majeed Bhat; Tim J Bradley; Steve D Colan; Greg Ensing; Jessica Gorentz; Haleh Heydarian; J Blaine John; Wyman W Lai; Jami C Levine; William T Mahle; Stephen G Miller; Richard G Ohye; Gail D Pearson; Girish S Shirali; Pierre C Wong; Meryl S Cohen Journal: Circulation Date: 2012-04-21 Impact factor: 29.690
Authors: Douglas Y Mah; Henry Cheng; Mark E Alexander; Lynn Sleeper; Jane W Newburger; Pedro J Del Nido; Ravi R Thiagarajan; Satish K Rajagopal Journal: J Thorac Cardiovasc Surg Date: 2016-04-11 Impact factor: 5.209
Authors: Mary C Niu; Heather A Dickerson; Judson A Moore; Caridad de la Uz; Santiago O Valdés; Jeffrey J Kim; David E Bard; Shaine A Morris; Christina Y Miyake Journal: Heart Rhythm Date: 2017-12-08 Impact factor: 6.343
Authors: Carolyn M Wilhelm; Diane Paulus; Clifford L Cua; Naomi J Kertesz; John P Cheatham; Mark Galantowicz; Richard P Fernandez Journal: Pediatr Cardiol Date: 2015-12-14 Impact factor: 1.655